Cartesian Therapeutics, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
RNAC$7.02-6.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.
| CARTESIAN THERAPEUTICS, INC. | ||
| Date: November 6, 2025 | By: | /s/ Carsten Brunn, Ph.D. |
|---|---|---|
| Carsten Brunn, Ph.D. | ||
| President and Chief Executive Officer, and Director | ||
| (Principal Executive Officer) | ||
| Date: November 6, 2025 | By: | /s/ Blaine Davis |
| Blaine Davis | ||
| Chief Financial Officer | ||
| (Principal Financial Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.